Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat
E Smeland, R M Bremnes, A Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2010
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
T Tandstad, G Cohn-Cedermark, O Dahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Blood pressure and body mass index in long-term survivors of testicular cancer
H Sagstuen, N Aass, S D Fosså, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model
E Smeland, O M Fuskevåg, K Nymann, et al.
Journal of Cancer Survivorship : Research and Practice
|
September 17, 2008
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
H S Haugnes, N Aass, S D Fosså, et al.
British Journal of Cancer
|
November 22, 2012
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
M Brydøy, S D Fosså, O Klepp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Components of the metabolic syndrome in long-term survivors of testicular cancer
H S Haugnes, N Aass, S D Fosså, et al.
British Journal of Cancer
|
October 19, 2006
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
C von Plessen, B Bergman, O Andresen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer
R M Bremnes, R Veve, E Gabrielson, et al.
British Journal of Cancer
|
June 28, 2007
Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
N Helbekkmo, S H Sundstrøm, U Aasebø, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat
E Smeland, R M Bremnes, A Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 10, 2010
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
T Tandstad, G Cohn-Cedermark, O Dahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2005
Blood pressure and body mass index in long-term survivors of testicular cancer
H Sagstuen, N Aass, S D Fosså, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1996
High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model
E Smeland, O M Fuskevåg, K Nymann, et al.
Journal of Cancer Survivorship : Research and Practice
|
September 17, 2008
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
H S Haugnes, N Aass, S D Fosså, et al.
British Journal of Cancer
|
November 22, 2012
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
M Brydøy, S D Fosså, O Klepp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Components of the metabolic syndrome in long-term survivors of testicular cancer
H S Haugnes, N Aass, S D Fosså, et al.
British Journal of Cancer
|
October 19, 2006
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
C von Plessen, B Bergman, O Andresen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2002
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer
R M Bremnes, R Veve, E Gabrielson, et al.
British Journal of Cancer
|
June 28, 2007
Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
N Helbekkmo, S H Sundstrøm, U Aasebø, et al.
Page
of 5